In RCC, which is one of the most vascularized tumors, the von Hippel-Lindau (VHL) tumor suppressor gene is inactivated in 50–75% of the cases through mutations, hypermethylations, or loss of heterozygosity (7). Here, VHL is linked to renal cell adenocarcinoma.